Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Bonnetain

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102Gilles Crehange, Philippe Maingon, Karine Peignaux, et al.
Trials|September 25, 2014
Parenteral nutrition at the palliative phase of advanced cancer: the ALIM-K study protocol for a randomized controlled trialLionel Pazart, Elodie Cretin, Ghislain Grodard, et al.
Cancer Medicine|August 12, 2014
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic reviewFrédéric Fiteni, Thierry Nguyen, Dewi Vernerey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancerGilles Crehange, Celine Mirjolet, Melanie Gauthier, et al.
Journal of Hematology & Oncology|May 16, 2015
The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomasStefano Kim, Frederic Fiteni, Sophie Paget-Bailly, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 5, 2009
Estimating the cost related to surveillance of colorectal cancer in a French populationCatherine Lejeune, Christine Binquet, Franck Bonnetain, et al.
Archives of Gynecology and Obstetrics|October 23, 2009
Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancerHervé Tixier, Jean Fraisse, Bruno Chauffert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Alternative end points to evaluate a therapeutic strategy in advanced colorectal cancer: evaluation of progression-free survival, duration of disease control, and time to failure of strategy--an Aide et Recherche en Cancerologie Digestive Group StudyBenoist Chibaudel, Franck Bonnetain, Qian Shi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2010
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinomaFranck Bonnetain, Laetitia Dahan, Emilie Maillard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 12, 2008
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trialsFranck Bonnetain, Xavier Paoletti, Sandra Collette, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102Gilles Crehange, Philippe Maingon, Karine Peignaux, et al.
Trials|September 25, 2014
Parenteral nutrition at the palliative phase of advanced cancer: the ALIM-K study protocol for a randomized controlled trialLionel Pazart, Elodie Cretin, Ghislain Grodard, et al.
Cancer Medicine|August 12, 2014
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic reviewFrédéric Fiteni, Thierry Nguyen, Dewi Vernerey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancerGilles Crehange, Celine Mirjolet, Melanie Gauthier, et al.
Journal of Hematology & Oncology|May 16, 2015
The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomasStefano Kim, Frederic Fiteni, Sophie Paget-Bailly, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 5, 2009
Estimating the cost related to surveillance of colorectal cancer in a French populationCatherine Lejeune, Christine Binquet, Franck Bonnetain, et al.
Archives of Gynecology and Obstetrics|October 23, 2009
Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancerHervé Tixier, Jean Fraisse, Bruno Chauffert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Alternative end points to evaluate a therapeutic strategy in advanced colorectal cancer: evaluation of progression-free survival, duration of disease control, and time to failure of strategy--an Aide et Recherche en Cancerologie Digestive Group StudyBenoist Chibaudel, Franck Bonnetain, Qian Shi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2010
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinomaFranck Bonnetain, Laetitia Dahan, Emilie Maillard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 12, 2008
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trialsFranck Bonnetain, Xavier Paoletti, Sandra Collette, et al.
Pageof 17